News and announcements

We are delighted to announce that alveofit® has won the Vedanta Spark 2.0 competition for the theme ‘Zero Harm’. This is a tremendous achievement and a testament to the hard work and dedication of our team. The Vedanta Spark 2.0

As a part of this partnership with alveofit, AstraZeneca will provide alveofit IoT enabled handheld spirometers to the clinics and hospitals to enable point of care spirometry for optimised management of different lung associated non-communicable diseases Under the aegis of

We are working round the clock to build awareness about respiratory care continuously

Get to know about alveoair® digital spirometer

Share with your Friends and connections

Your child's doctor will tell you how often to give your child #breathing_treatments, based on how severe their #asthma is. #asthmaproblems #asthmaawareness #asthmalife #asthmadisease #asthmaattack #lunghealth pic.twitter.com/nXDJsqoEWf

Now you can easily take care of your lung health with alveofit®, keep track of your lung function and do spirometry tests anytime anywhere using alveoair®, Manage your medication smartly with alveodot®. #lunghealth #spirometer #asthma #copd #medicaldevices #lungfunctiontest pic.twitter.com/xwb0KcnewO

Asthma is a serious disease that affects about 25 million people, including 8 percent of adults and 7% of children, who suffer from asthma. Currently, there are about 5.1 million children under the age of 18 with asthma. https://t.co/UFSfw6ghKP #childasthma #childhoodasthma